🟢 Immunic is trading 5.36% up today after Wedbush initiated Outperform coverage

Immunic is trading 5.36% up at $16.89 after Wedbush initiated coverage on August 17, 2026, with an Outperform rating and a $45 price target.

• H.C. Wainwright also rates Immunic Buy and has a $22 price target, adding to positive sentiment.
• Broader markets are declining: Nasdaq is down 1.12% and S&P 500 is down 0.51%, as company-specific optimism outweighs risk-off conditions.